| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | mesenchyme migration | 4.44e-06 | 5 | 159 | 3 | GO:0090131 | |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 1.15e-05 | 39 | 160 | 5 | GO:0031463 | |
| Domain | Gal_Oxase/kelch_b-propeller | 9.29e-06 | 59 | 155 | 6 | IPR011043 | |
| Domain | Kelch_1 | 2.51e-05 | 70 | 155 | 6 | PF01344 | |
| Domain | Kelch_1 | 2.51e-05 | 70 | 155 | 6 | IPR006652 | |
| Domain | ACTINS_1 | 3.05e-05 | 8 | 155 | 3 | PS00406 | |
| Domain | BTB | 1.12e-04 | 131 | 155 | 7 | PF00651 | |
| Domain | Kelch | 1.19e-04 | 58 | 155 | 5 | SM00612 | |
| Domain | BTB | 1.31e-04 | 180 | 155 | 8 | SM00225 | |
| Domain | BACK | 1.40e-04 | 60 | 155 | 5 | SM00875 | |
| Domain | BACK | 1.51e-04 | 61 | 155 | 5 | IPR011705 | |
| Domain | BACK | 1.51e-04 | 61 | 155 | 5 | PF07707 | |
| Domain | BTB/POZ_dom | 1.59e-04 | 185 | 155 | 8 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 1.84e-04 | 189 | 155 | 8 | IPR011333 | |
| Domain | Actin_CS | 2.90e-04 | 16 | 155 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 3.50e-04 | 17 | 155 | 3 | PS00432 | |
| Domain | BTB | 3.82e-04 | 160 | 155 | 7 | PS50097 | |
| Domain | COE | 4.06e-04 | 4 | 155 | 2 | PS01345 | |
| Domain | Bestrophin | 4.06e-04 | 4 | 155 | 2 | PF01062 | |
| Domain | Transcription_factor_COE | 4.06e-04 | 4 | 155 | 2 | IPR003523 | |
| Domain | Bestrophin/UPF0187 | 4.06e-04 | 4 | 155 | 2 | IPR021134 | |
| Domain | COE_HLH | 4.06e-04 | 4 | 155 | 2 | IPR032201 | |
| Domain | COE_DBD | 4.06e-04 | 4 | 155 | 2 | IPR032200 | |
| Domain | Bestrophin | 4.06e-04 | 4 | 155 | 2 | IPR000615 | |
| Domain | Transcription_factor_COE_CS | 4.06e-04 | 4 | 155 | 2 | IPR018350 | |
| Domain | COE1_HLH | 4.06e-04 | 4 | 155 | 2 | PF16423 | |
| Domain | COE1_DBD | 4.06e-04 | 4 | 155 | 2 | PF16422 | |
| Domain | Actin/actin-like_CS | 4.17e-04 | 18 | 155 | 3 | IPR020902 | |
| Domain | BTB-kelch_protein | 4.38e-04 | 43 | 155 | 4 | IPR017096 | |
| Domain | ACTINS_ACT_LIKE | 4.93e-04 | 19 | 155 | 3 | PS01132 | |
| Domain | - | 6.68e-04 | 48 | 155 | 4 | 2.120.10.80 | |
| Domain | Kelch-typ_b-propeller | 1.12e-03 | 55 | 155 | 4 | IPR015915 | |
| Domain | PKD | 1.40e-03 | 7 | 155 | 2 | PF00801 | |
| Pubmed | 9.08e-09 | 57 | 162 | 7 | 34878901 | ||
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 8.15e-08 | 24 | 162 | 5 | 30190310 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 9.92e-08 | 3 | 162 | 3 | 7780165 | |
| Pubmed | TBX1 and Basal Cell Carcinoma: Expression and Interactions with Gli2 and Dvl2 Signaling. | 9.92e-08 | 3 | 162 | 3 | 31963474 | |
| Pubmed | 1.46e-07 | 11 | 162 | 4 | 22207710 | ||
| Pubmed | 1.79e-07 | 87 | 162 | 7 | 37495603 | ||
| Pubmed | 4.38e-07 | 14 | 162 | 4 | 17411366 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 11580270 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 11971873 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 32362246 | ||
| Pubmed | The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells. | 9.85e-07 | 5 | 162 | 3 | 27477274 | |
| Pubmed | Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. | 1.66e-06 | 19 | 162 | 4 | 18316483 | |
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 1.96e-06 | 6 | 162 | 3 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 1.96e-06 | 6 | 162 | 3 | 10074138 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 1.96e-06 | 6 | 162 | 3 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 1.96e-06 | 6 | 162 | 3 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 1.96e-06 | 6 | 162 | 3 | 11709093 | |
| Pubmed | Tbx1 regulates proliferation and differentiation of multipotent heart progenitors. | 1.96e-06 | 6 | 162 | 3 | 19745164 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 10049817 | ||
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 1.96e-06 | 6 | 162 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 1.96e-06 | 6 | 162 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 1.96e-06 | 6 | 162 | 3 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 1.96e-06 | 6 | 162 | 3 | 8661406 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 23017337 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 1.96e-06 | 6 | 162 | 3 | 23875777 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 9841925 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 22535526 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 3.42e-06 | 7 | 162 | 3 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 3.42e-06 | 7 | 162 | 3 | 22640593 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 33990333 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 3.42e-06 | 7 | 162 | 3 | 17504171 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 22465675 | ||
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 3.42e-06 | 7 | 162 | 3 | 9384381 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 30289203 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | CUL3 CAND1 UGGT1 GPS1 ACTA2 CKAP5 HNRNPA2B1 KBTBD7 PDIA4 CCT5 KLHL13 KPNA1 | 3.96e-06 | 495 | 162 | 12 | 28581483 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CUL3 CAND1 MAN2B1 EIF4A3 UGGT1 GPS1 ACTA1 DVL2 HNRNPA2B1 AKAP12 PDIA4 BLMH RBM12 KIF15 CCT5 PLPBP RIC8A SMS DNM1 DYNC1H1 KPNA1 | 4.44e-06 | 1455 | 162 | 21 | 22863883 |
| Pubmed | Fibulin-1 is required for morphogenesis of neural crest-derived structures. | 5.46e-06 | 8 | 162 | 3 | 18538758 | |
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 20096780 | ||
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 14694110 | ||
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 20147394 | ||
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 23260110 | ||
| Pubmed | 5.71e-06 | 272 | 162 | 9 | 31010829 | ||
| Pubmed | 6.26e-06 | 26 | 162 | 4 | 24742657 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | VTN CAND1 ATP5PO EIF4A3 UGGT1 ACTA1 CKAP5 ACTC1 ADAR PRPF40A HNRNPA2B1 ITPR3 PDIA4 BLMH CCT5 TMPO DYNC1H1 | 6.48e-06 | 1024 | 162 | 17 | 24711643 |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 8.16e-06 | 9 | 162 | 3 | 10556093 | |
| Pubmed | Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. | 8.16e-06 | 9 | 162 | 3 | 12297046 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 8.16e-06 | 9 | 162 | 3 | 8892894 | |
| Pubmed | 8.16e-06 | 9 | 162 | 3 | 18775311 | ||
| Pubmed | CUL3 AMPD1 CAND1 ATP5PO EIF4A3 UGGT1 ACTC1 ADAR HNRNPA2B1 PDIA4 ORC4 ABCB10 CCT5 DYNC1H1 | 8.36e-06 | 725 | 162 | 14 | 27025967 | |
| Pubmed | 8.42e-06 | 59 | 162 | 5 | 19295130 | ||
| Pubmed | CUL3 GDPD1 FKBP15 CAND1 ERAP1 EIF4A3 CKAP5 ACTC1 ITGA1 MED1 ADAR PRPF40A HNRNPA2B1 ITPR3 KIF15 TMPO ADPGK DYNC1H1 | 9.42e-06 | 1168 | 162 | 18 | 19946888 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | CAND1 ATP5PO EIF4A3 ACTA2 CKAP5 ACTC1 MTERF4 ADAR PRPF40A HNRNPA2B1 PDIA4 CCT5 TMPO DYNC1H1 KPNA1 | 1.10e-05 | 847 | 162 | 15 | 35235311 |
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 1907279 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 15996652 | ||
| Pubmed | Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. | 1.16e-05 | 10 | 162 | 3 | 21749862 | |
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 1.16e-05 | 10 | 162 | 3 | 1991513 | |
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 23575248 | ||
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 30962377 | ||
| Pubmed | PRDM16 regulates arterial development and vascular integrity. | 1.59e-05 | 11 | 162 | 3 | 37324380 | |
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 1.59e-05 | 11 | 162 | 3 | 23294842 | |
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 25684205 | ||
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 1.59e-05 | 11 | 162 | 3 | 19639585 | |
| Pubmed | CUL3 CAND1 EBF3 EIF4A3 CKAP5 MED1 ADAR HNRNPA2B1 PDIA4 BLMH RBM12 RESF1 CCT5 KLF5 TMPO SMS DYNC1H1 | 1.69e-05 | 1103 | 162 | 17 | 34189442 | |
| Pubmed | SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice. | 2.12e-05 | 12 | 162 | 3 | 31042497 | |
| Pubmed | 2.12e-05 | 12 | 162 | 3 | 23071112 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 20706863 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 3023046 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23744056 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15703215 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 3075543 | ||
| Pubmed | Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. | 2.16e-05 | 2 | 162 | 2 | 19468071 | |
| Pubmed | alpha-Actin proteins and gene transcripts are colocalized in embryonic mouse muscle. | 2.16e-05 | 2 | 162 | 2 | 1893870 | |
| Pubmed | Cullin3 is a KLHL10-interacting protein preferentially expressed during late spermiogenesis. | 2.16e-05 | 2 | 162 | 2 | 16162871 | |
| Pubmed | Muscle specific expression of Cre recombinase under two actin promoters in transgenic mice. | 2.16e-05 | 2 | 162 | 2 | 10686609 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 18075312 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 2731651 | ||
| Pubmed | A fetal skeletal muscle actin mRNA in the mouse and its identity with cardiac actin mRNA. | 2.16e-05 | 2 | 162 | 2 | 6897014 | |
| Pubmed | 2.19e-05 | 322 | 162 | 9 | 26514267 | ||
| Pubmed | FKBP15 IQSEC3 CKAP5 SNX19 PLEKHG1 STARD9 KLHL13 PACS2 CAMTA1 DYNC1H1 | 2.30e-05 | 407 | 162 | 10 | 12693553 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX10 ZBTB38 EBF3 E4F1 EBF1 TEAD1 DMBX1 NR2F2 GLI2 KLF5 HEY2 DLX2 CAMTA1 TBX1 TP73 | 2.46e-05 | 908 | 162 | 15 | 19274049 |
| Pubmed | 2.74e-05 | 13 | 162 | 3 | 24821700 | ||
| Pubmed | 2.74e-05 | 13 | 162 | 3 | 22421355 | ||
| Pubmed | Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. | 2.74e-05 | 13 | 162 | 3 | 18400219 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | CUL3 CAND1 ADAMTS1 UGGT1 ACTA2 CKAP5 ACTC1 ADAR PRPF40A HNRNPA2B1 AKAP12 PDIA4 BLMH CCT5 TMPO DYNC1H1 KPNA1 | 2.83e-05 | 1149 | 162 | 17 | 35446349 |
| Pubmed | 3.48e-05 | 14 | 162 | 3 | 21923909 | ||
| Pubmed | CUL3 SDK2 WAPL CAND1 KIF26A EIF4A3 RBM12 CCT5 ZBTB5 ESPL1 ACAP3 | 4.12e-05 | 529 | 162 | 11 | 14621295 | |
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 4.22e-05 | 198 | 162 | 7 | 20881960 | |
| Pubmed | 4.33e-05 | 15 | 162 | 3 | 24598388 | ||
| Pubmed | Serum response factor is required for sprouting angiogenesis and vascular integrity. | 4.86e-05 | 43 | 162 | 4 | 18804439 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 4.94e-05 | 203 | 162 | 7 | 22083510 | |
| Pubmed | Functional equivalence of Brn3 POU-domain transcription factors in mouse retinal neurogenesis. | 5.31e-05 | 16 | 162 | 3 | 15647317 | |
| Pubmed | Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose. | 5.31e-05 | 16 | 162 | 3 | 16638982 | |
| Pubmed | Serum response factor is essential for mesoderm formation during mouse embryogenesis. | 5.31e-05 | 16 | 162 | 3 | 9799237 | |
| Pubmed | 5.31e-05 | 16 | 162 | 3 | 18397758 | ||
| Pubmed | USP25 regulates Wnt signaling by controlling the stability of tankyrases. | 5.31e-05 | 16 | 162 | 3 | 28619731 | |
| Pubmed | 5.31e-05 | 16 | 162 | 3 | 16036220 | ||
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 6.12e-05 | 210 | 162 | 7 | 26217791 | |
| Pubmed | 6.43e-05 | 17 | 162 | 3 | 17360745 | ||
| Pubmed | 6.43e-05 | 17 | 162 | 3 | 8997639 | ||
| Interaction | FBXL17 interactions | 2.98e-07 | 85 | 155 | 8 | int:FBXL17 | |
| Interaction | PXDNL interactions | 1.19e-05 | 19 | 155 | 4 | int:PXDNL | |
| GeneFamily | Actins | 3.98e-06 | 6 | 107 | 3 | 929 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.48e-05 | 134 | 107 | 7 | 861 | |
| GeneFamily | Bestrophins | 2.07e-04 | 4 | 107 | 2 | 866 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CAND1 KIF26A EBF3 FAT3 ACTA1 ACTA2 LAMA4 ACTC1 SEMA5A TEAD1 GDF10 PCDH17 FAM193A GLI2 KLF5 CAMTA1 DNM1 CPLANE1 ARMH4 | 6.28e-06 | 806 | 154 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | EBF3 FAT3 ACTA1 ACTA2 LAMA4 ACTC1 SEMA5A PCDH17 FAM193A KLF5 DNM1 CPLANE1 ARMH4 | 8.86e-06 | 407 | 154 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | CAND1 ACTA2 LAMA4 ACTC1 SEMA5A ITGA1 TEAD1 GDF10 PCDH17 VPS13A SORCS3 CPLANE1 | 3.09e-05 | 393 | 154 | 12 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_100 | 4.11e-05 | 87 | 154 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_100 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_100 | 4.76e-05 | 28 | 154 | 4 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | FAT3 ACTA2 ACTC1 MUC16 NT5DC3 NR2F2 GLI2 KLHL13 SORCS3 DNM1 ARMH4 | 9.07e-05 | 373 | 154 | 11 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | KIF26A FAT3 LAMA4 SEMA5A TEAD1 GDF10 PCDH17 FAM193A DNM1 CPLANE1 | 9.66e-05 | 312 | 154 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 1.09e-04 | 149 | 154 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | KBTBD6 FAT3 ACTA2 MUC16 SEMA5A TBC1D8B KBTBD7 NR2F2 PDIA4 STARD9 GLI2 KLHL13 GMPR DNM1 ZMAT1 ARMH4 | 1.50e-04 | 768 | 154 | 16 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | ACTA1 THEM5 LAMA4 ACTC1 SEMA5A KBTBD7 PCDH17 PLEKHG1 FAM193A GLI2 KLF5 VPS13A HEY2 DLX2 DNM1 CPLANE1 | 1.53e-04 | 769 | 154 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 2.03e-04 | 116 | 154 | 6 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k3_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 2.05e-04 | 165 | 154 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | ADAMTS1 FAT3 ACTA2 LAMA4 SEMA5A EBF1 PMEPA1 GLI2 KLHL13 HEY2 | 1.82e-09 | 186 | 163 | 10 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | ADAMTS1 FAT3 ACTA2 LAMA4 SEMA5A EBF1 PMEPA1 GLI2 KLHL13 HEY2 | 2.35e-09 | 191 | 163 | 10 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-08 | 186 | 163 | 9 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.78e-08 | 191 | 163 | 9 | 239c1e68eb1cbe3e137a99fbd6eeb8d64c919ffd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-08 | 191 | 163 | 9 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-08 | 192 | 163 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 3.95e-08 | 192 | 163 | 9 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-08 | 194 | 163 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.51e-08 | 195 | 163 | 9 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.51e-08 | 195 | 163 | 9 | 9b3fa1d42ec5aa2911f27a99cd8b57714c6bd604 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.93e-08 | 197 | 163 | 9 | b7e399b8e1a1ffc2b359f14929f199b93d9bbcce | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 5.14e-08 | 198 | 163 | 9 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.37e-08 | 199 | 163 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.37e-08 | 199 | 163 | 9 | c8bc05dece8b8a87d4a7a3e8112b924e15217de1 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-08 | 199 | 163 | 9 | 78b245d40c1e169ff2d26907b63d732e34529c5f | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.37e-08 | 199 | 163 | 9 | 8e1e95c3a4b856415af208be6ad977e575bac189 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.37e-08 | 199 | 163 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-08 | 199 | 163 | 9 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.61e-08 | 200 | 163 | 9 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.61e-08 | 200 | 163 | 9 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-07 | 167 | 163 | 8 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-07 | 170 | 163 | 8 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-07 | 171 | 163 | 8 | 285533ca2a6a411773313166bee35542f34d1a3c | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.03e-07 | 177 | 163 | 8 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.59e-07 | 181 | 163 | 8 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 4.41e-07 | 186 | 163 | 8 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.41e-07 | 186 | 163 | 8 | c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.47e-07 | 127 | 163 | 7 | f808c727c0817ed10e76eaffa9493a516e9a6b50 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 4.59e-07 | 187 | 163 | 8 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-07 | 189 | 163 | 8 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-07 | 189 | 163 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-07 | 190 | 163 | 8 | a7f6c38bbf451f166febb21e6719d4afced4035e | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 5.18e-07 | 190 | 163 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-07 | 191 | 163 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.84e-07 | 193 | 163 | 8 | 47d189bac0ef4df2f5c6dd987e46aca85bd7e2af | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.84e-07 | 193 | 163 | 8 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.07e-07 | 194 | 163 | 8 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|metastatic_Brain / Location, Cell class and cell subclass | 6.07e-07 | 194 | 163 | 8 | d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.07e-07 | 194 | 163 | 8 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.07e-07 | 194 | 163 | 8 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-07 | 195 | 163 | 8 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-07 | 195 | 163 | 8 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.31e-07 | 195 | 163 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-07 | 195 | 163 | 8 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | (5)_Fibroblast-K_(Pericytes)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.56e-07 | 196 | 163 | 8 | e3c89c5bd674289738d5590ebfd30c605f5156a5 | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 6.56e-07 | 196 | 163 | 8 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-07 | 196 | 163 | 8 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.56e-07 | 196 | 163 | 8 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.56e-07 | 196 | 163 | 8 | 9a420a4eb46cb554bec641726fea5398ff60f630 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.56e-07 | 196 | 163 | 8 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-07 | 196 | 163 | 8 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-07 | 196 | 163 | 8 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-07 | 196 | 163 | 8 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.81e-07 | 197 | 163 | 8 | 452be45f4aac8459dd860493171f5f715368d663 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-07 | 197 | 163 | 8 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-07 | 197 | 163 | 8 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-07 | 197 | 163 | 8 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.35e-07 | 199 | 163 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.35e-07 | 199 | 163 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 7.35e-07 | 199 | 163 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-07 | 199 | 163 | 8 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | proximal-3-mesenchymal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.64e-07 | 200 | 163 | 8 | 94250991f78ea56810412d00a4bb645eb975478c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.64e-07 | 200 | 163 | 8 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.64e-07 | 200 | 163 | 8 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.64e-07 | 200 | 163 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.64e-07 | 200 | 163 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | proximal-mesenchymal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.64e-07 | 200 | 163 | 8 | 29f3a5c85404c6537d6405d599ebae281e0d4d4f | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.64e-07 | 200 | 163 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-06 | 166 | 163 | 7 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-06 | 166 | 163 | 7 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 3.28e-06 | 171 | 163 | 7 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 3.54e-06 | 173 | 163 | 7 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 177 | 163 | 7 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 177 | 163 | 7 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-06 | 178 | 163 | 7 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | COPD-Stromal-SMC|COPD / Disease state, Lineage and Cell class | 4.43e-06 | 179 | 163 | 7 | 5c705627bd13a5b2c7b0062fb3d94e4eb1589327 | |
| ToppCell | Control-Stromal-SMC|Control / Disease state, Lineage and Cell class | 4.43e-06 | 179 | 163 | 7 | 1378051bc62009eec2dbecf3d5d89baedbeb84eb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.60e-06 | 180 | 163 | 7 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 4.60e-06 | 180 | 163 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-06 | 180 | 163 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-06 | 181 | 163 | 7 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 182 | 163 | 7 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.94e-06 | 182 | 163 | 7 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 182 | 163 | 7 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.12e-06 | 183 | 163 | 7 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 5.12e-06 | 183 | 163 | 7 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | Control-Stromal-SMC|World / Disease state, Lineage and Cell class | 5.31e-06 | 184 | 163 | 7 | 88b1a4c9a96a99fc3a39f7a2c3d0838739606f3e | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 5.50e-06 | 185 | 163 | 7 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | wk_08-11-Epithelial-PNS-COL20A1+_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.50e-06 | 185 | 163 | 7 | abec2a49fe0f0fa4cba49347207a1ee317333657 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 5.50e-06 | 185 | 163 | 7 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.70e-06 | 186 | 163 | 7 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 186 | 163 | 7 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.70e-06 | 186 | 163 | 7 | 0b2ce9b8a4382d583240647217ad5e2d3fa555c1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 186 | 163 | 7 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 186 | 163 | 7 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-06 | 187 | 163 | 7 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.90e-06 | 187 | 163 | 7 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.90e-06 | 187 | 163 | 7 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| Disease | Moyamoya disease (implicated_via_orthology) | 7.96e-06 | 8 | 156 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 7.96e-06 | 8 | 156 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 7.96e-06 | 8 | 156 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 7.96e-06 | 8 | 156 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | uncharacterized protein C17orf78 measurement | 8.30e-05 | 3 | 156 | 2 | EFO_0802191 | |
| Disease | colorectal health | 1.01e-04 | 201 | 156 | 7 | EFO_0008460 | |
| Disease | Mammary Carcinoma, Human | ADAMTS1 WNT10B ACTA2 TRMT11 GDF10 ADAR AKAP12 CCT5 HEY2 RIC8A TP73 | 1.17e-04 | 525 | 156 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | ADAMTS1 WNT10B ACTA2 TRMT11 GDF10 ADAR AKAP12 CCT5 HEY2 RIC8A TP73 | 1.17e-04 | 525 | 156 | 11 | C1257931 |
| Disease | Mammary Neoplasms | ADAMTS1 WNT10B ACTA2 TRMT11 GDF10 ADAR AKAP12 CCT5 HEY2 RIC8A TP73 | 1.21e-04 | 527 | 156 | 11 | C1458155 |
| Disease | Breast Carcinoma | ADAMTS1 WNT10B ACTA2 TRMT11 GDF10 ADAR AKAP12 CCT5 HEY2 RIC8A TP73 | 1.44e-04 | 538 | 156 | 11 | C0678222 |
| Disease | asparagine measurement, amino acid measurement | 1.65e-04 | 4 | 156 | 2 | EFO_0005134, EFO_0009766 | |
| Disease | Hypertrophic Cardiomyopathy | 2.39e-04 | 57 | 156 | 4 | C0007194 | |
| Disease | Colorectal Carcinoma | AMPD1 ITPRID1 AKAP12 CNPPD1 ABCB10 SULT2B1 ABCA6 GUCY2C KLF5 VPS13A DIP2C TBX1 | 3.73e-04 | 702 | 156 | 12 | C0009402 |
| Disease | Malignant neoplasm of breast | MICAL1 ADAMTS1 WNT10B ACTA2 KBTBD8 TRMT11 GDF10 ADAR AKAP12 ABCB10 CCT5 HEY2 DIP2C RIC8A TP73 | 5.98e-04 | 1074 | 156 | 15 | C0006142 |
| Disease | colorectal adenoma | 7.04e-04 | 33 | 156 | 3 | EFO_0005406 | |
| Disease | Primary dilated cardiomyopathy | 7.69e-04 | 34 | 156 | 3 | cv:C0007193 | |
| Disease | epilepsy (is_implicated_in) | 9.76e-04 | 9 | 156 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | free cholesterol in medium LDL measurement | 1.24e-03 | 40 | 156 | 3 | EFO_0022268 | |
| Disease | nucleus accumbens volume change measurement | 1.48e-03 | 11 | 156 | 2 | EFO_0021493 | |
| Disease | serum metabolite measurement | ERAP1 ASPG PKD1L1 VEPH1 SLC22A11 CKAP5 THEM5 TEAD1 HEY2 DIP2C SORCS3 PCSK9 ARMH4 | 1.59e-03 | 945 | 156 | 13 | EFO_0005653 |
| Disease | Familial dilated cardiomyopathy | 1.64e-03 | 44 | 156 | 3 | C0340427 | |
| Disease | multisite chronic pain | 1.65e-03 | 95 | 156 | 4 | EFO_0010100 | |
| Disease | smoking cessation | 1.77e-03 | 325 | 156 | 7 | EFO_0004319 | |
| Disease | hemoglobin A1 measurement | CUL3 ZBTB38 SLC38A9 EBF1 SLC25A37 PLEKHG1 ABCB10 VPS13A RIC8A | 1.86e-03 | 520 | 156 | 9 | EFO_0007629 |
| Disease | Cardiomyopathy | 1.98e-03 | 47 | 156 | 3 | cv:C0878544 | |
| Disease | Cardiomyopathy, Dilated | 2.11e-03 | 48 | 156 | 3 | C0007193 | |
| Disease | phospholipids in medium LDL measurement | 2.23e-03 | 49 | 156 | 3 | EFO_0022183 | |
| Disease | free cholesterol in LDL measurement | 2.37e-03 | 50 | 156 | 3 | EFO_0022266 | |
| Disease | free cholesterol in large LDL measurement | 2.51e-03 | 51 | 156 | 3 | EFO_0022176 | |
| Disease | phospholipids in very small VLDL measurement | 2.51e-03 | 51 | 156 | 3 | EFO_0022300 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.52e-03 | 346 | 156 | 7 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Schizophrenia | SOX10 ARHGAP32 GPS1 CSMD2 PCDH17 CNPPD1 KLF5 KCNS3 ARHGAP18 DNM1 TBX1 KPNA1 | 2.64e-03 | 883 | 156 | 12 | C0036341 |
| Disease | total lipids in medium LDL | 2.65e-03 | 52 | 156 | 3 | EFO_0022180 | |
| Disease | total lipids in LDL measurement | 2.65e-03 | 52 | 156 | 3 | EFO_0022308 | |
| Disease | myocardial infarction | 2.68e-03 | 350 | 156 | 7 | EFO_0000612 | |
| Disease | Alobar Holoprosencephaly | 2.79e-03 | 15 | 156 | 2 | C0431363 | |
| Disease | phospholipids in large LDL measurement | 2.80e-03 | 53 | 156 | 3 | EFO_0022174 | |
| Disease | free cholesterol in small LDL measurement | 2.80e-03 | 53 | 156 | 3 | EFO_0022271 | |
| Disease | Lobar Holoprosencephaly | 3.17e-03 | 16 | 156 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 3.17e-03 | 16 | 156 | 2 | C0751617 | |
| Disease | Drug habituation | 3.30e-03 | 115 | 156 | 4 | C0013170 | |
| Disease | Drug abuse | 3.30e-03 | 115 | 156 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.30e-03 | 115 | 156 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.30e-03 | 115 | 156 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.30e-03 | 115 | 156 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.30e-03 | 115 | 156 | 4 | C1510472 | |
| Disease | antihyperlipidemic drug use measurement | 3.30e-03 | 115 | 156 | 4 | EFO_0803367 | |
| Disease | Substance Dependence | 3.30e-03 | 115 | 156 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.30e-03 | 115 | 156 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.30e-03 | 115 | 156 | 4 | C0029231 | |
| Disease | Substance abuse problem | 3.40e-03 | 116 | 156 | 4 | C0740858 | |
| Disease | total lipids in large LDL | 3.44e-03 | 57 | 156 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 3.44e-03 | 57 | 156 | 3 | EFO_0021901 | |
| Disease | Holoprosencephaly | 3.59e-03 | 17 | 156 | 2 | C0079541 | |
| Disease | phospholipids in LDL measurement | 3.61e-03 | 58 | 156 | 3 | EFO_0022294 | |
| Disease | Colorectal Neoplasms | 3.65e-03 | 277 | 156 | 6 | C0009404 | |
| Disease | phospholipids in small LDL measurement | 3.79e-03 | 59 | 156 | 3 | EFO_0022297 | |
| Disease | bone mineral content measurement | 5.10e-03 | 130 | 156 | 4 | EFO_0007621 | |
| Disease | age at initiation of smoking | 5.20e-03 | 66 | 156 | 3 | EFO_0021784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FPTMDHVVEAGFMTT | 151 | Q8N1M1 | |
| FPTMEHVVDAGFMSQ | 151 | Q8NFU0 | |
| AAGSMMQTHGDFDVA | 241 | Q96RK4 | |
| FSHDLSNGAMNMLEV | 231 | Q9BRR6 | |
| SEGGASTMAYMHVAE | 836 | Q9Y6Y1 | |
| STMAYMHVAEVVSAA | 841 | Q9Y6Y1 | |
| VFSHSEMMGVTLNST | 1166 | Q7Z408 | |
| MESAGIHETTYNSIM | 271 | P68133 | |
| ESQVHMMAAAVADGT | 886 | Q02952 | |
| EMSQTAQVSHEGMEG | 341 | Q86TY3 | |
| NEMELAHSSFSEMQT | 811 | Q8N139 | |
| MESAGIHETTYNSIM | 271 | P62736 | |
| MSDMTKLHQAVAAGD | 6 | B4E2M5 | |
| MGSAHMTVGELSSFL | 421 | Q9NRK6 | |
| ILDSMLSFMHAQSSF | 186 | Q96P50 | |
| AGALTHLMTAFMIAD | 576 | P23109 | |
| MTGVFDSLVADMHST | 1 | Q07687 | |
| SAMAMAALTTFVAGA | 1081 | Q96F81 | |
| GENNFTDTMRHMLSS | 181 | P78312 | |
| GLSVHTDMASVTKAM | 416 | O14641 | |
| TAQLAGHSMDYSQEM | 26 | Q8NB25 | |
| TQGVVSAFSTMMSVH | 121 | P48047 | |
| VSVHGMPFSAMENDV | 306 | Q9NTZ6 | |
| MASDQMARVFADVHS | 1091 | O14917 | |
| DCASHFEQMAAASMH | 451 | O00391 | |
| HASPMSADRVVAFMD | 276 | P24468 | |
| ETMLVADQSMAEFHG | 261 | Q9UHI8 | |
| HNGSYEISVLMMGNS | 31 | P25092 | |
| MSEMSSFLHIGDIVS | 1 | Q14573 | |
| TASHPFMTAVDLMEA | 291 | O43929 | |
| ATQREAAAMTSSMAH | 161 | Q9UBP5 | |
| MTHGFSQLDVTTLMS | 5006 | Q8WXI7 | |
| SQGFSHSQMTALMSR | 9111 | Q8WXI7 | |
| MFFVHALTAMESGVL | 106 | Q6IF63 | |
| VNFLGTLSMHASMFV | 91 | Q96P67 | |
| TFTMMGPSESDNFSH | 116 | Q9NS87 | |
| AAFDEVKMAAHTMGN | 631 | P42166 | |
| LGFMVTHVTEMQDSF | 566 | Q6ZRS4 | |
| VVIHGTDTMAFAASM | 111 | Q86U10 | |
| ENGSDSFMHSMDPQL | 641 | Q05193 | |
| EFASHGMQNMTVVIS | 556 | Q9NR71 | |
| MLVFGGNTHNDTSMS | 566 | O75882 | |
| KMREANFTVSSMHGD | 296 | P38919 | |
| MADRAEMFSLSTFHS | 1 | Q13387 | |
| SMQDSEMILTATFHF | 121 | P55107 | |
| ISESDMHVSQMAISF | 701 | Q86VP6 | |
| IAHMVMGTTNQFSTR | 871 | Q9NZ08 | |
| SQAAAHVAGIAAMML | 386 | Q8NBP7 | |
| LNGTDMFHMVQSAGV | 2006 | Q9NYQ8 | |
| LQMFAIHSLSGMEST | 101 | Q8TCB6 | |
| LHGFSFMESSVLLAM | 106 | Q8NH59 | |
| VGFVHSSSQMAFMLT | 151 | Q8NH42 | |
| HGFNVAQTMFTLLMT | 561 | P35913 | |
| MHRMAAAFNTTVAAL | 386 | Q13098 | |
| SGDMASFLMTEARQH | 501 | Q5T1M5 | |
| AGGAHSFETAMMEST | 651 | Q14D04 | |
| SMHMAISGLSSFQRS | 296 | P54098 | |
| ASAMGINTAHQTGMI | 486 | Q96LU7 | |
| EMMDLQHGSLFFSTS | 61 | P07864 | |
| AHVMMVTCFDISVAA | 1856 | Q9ULI4 | |
| HGQPDVSAFDFTSMM | 356 | Q8TDZ2 | |
| HAMAAMPSSQETAEA | 1401 | P10070 | |
| TMAAFQHAVKIGTDM | 56 | Q8N9F7 | |
| AMCVHSMSEFQNEDG | 201 | Q9BQ31 | |
| TGGMYESQQASVTMH | 101 | Q8WVZ9 | |
| NSSHFMGTDKMASVF | 261 | Q96R08 | |
| AASTGGSHLTAVAMM | 241 | Q8NGR4 | |
| TLAAGSISMAEVMQH | 131 | Q86VP3 | |
| ASFEMEMSQTGFSAH | 371 | P56199 | |
| NHVDVLFSGRISMAM | 561 | A7KAX9 | |
| AHSGTLMMAFRDVTV | 476 | Q9UPP2 | |
| MHRLMGVNSTAAAAA | 1 | Q969W9 | |
| GMTASEMIICFDAAH | 281 | Q8NFY9 | |
| FTEHMISVSAFTIMG | 581 | Q9UMZ3 | |
| TTMSTMAAAEAAAAV | 266 | O75400 | |
| TTMDITHDGFGFMLA | 246 | O76062 | |
| ISAGEAHSMALSMSG | 196 | Q9UII4 | |
| DSSMDVFHLEGMTTS | 46 | O15350 | |
| VFHLEGMTTSVMAQF | 51 | O15350 | |
| SASSFAQGISMEAMS | 46 | Q6PI98 | |
| AMSGHIDQFLIATFM | 1576 | Q14008 | |
| HVSSSDLFLISMMVA | 116 | Q9BV87 | |
| GQELTDHMGMTASYT | 446 | Q14674 | |
| MEMESAAASTRFHQP | 1 | Q6JEL2 | |
| TDDAFPVHRVMMASA | 101 | Q9P2N7 | |
| SHASSEAGNMVMLGD | 1686 | Q8IZD9 | |
| AMKALHGEATNSMAS | 676 | P55265 | |
| MLQDDNTSAGLHFMA | 2531 | Q9H799 | |
| KAEENGSNSFMHSMV | 11 | Q6PK57 | |
| VNGYSLHAMNSLSAM | 6 | Q8NFW5 | |
| MHTTGSMEVSAESNR | 391 | P17213 | |
| DMSISNTTMDEFRQH | 476 | Q13618 | |
| MVKEAMDSGLHFTQS | 1971 | Q8TDW7 | |
| MLAGVKMSHAATSAF | 1146 | Q9Y2E4 | |
| NTSVHAGMMGVNSFS | 426 | Q9UH73 | |
| GESLMTHAMTFTAVS | 366 | Q13867 | |
| AATGIMSDQMQRHSY | 111 | Q9BSK0 | |
| HTVMTMGSDFQYENA | 311 | O00754 | |
| ATGTFDNEIVMMNHV | 161 | O60307 | |
| HMFVSTNLGESFMSI | 4006 | Q14204 | |
| MEGAMAVRVTAAHTA | 1 | Q66K89 | |
| DTVGTFEMAAVMSQH | 56 | P36959 | |
| HTGMMGVNSFSSQLA | 431 | Q9H4W6 | |
| SMLFAHQAMVEQLTG | 166 | Q6ZN32 | |
| THMLDNGSAVSTNMT | 51 | Q9NSA0 | |
| GHSEMMSLDESSFPA | 1976 | Q58EX2 | |
| MANMNSDSRHLGTSE | 1 | Q8NBW4 | |
| TAAFAAAISMVVAMA | 96 | Q16617 | |
| FGDSSGVEMRLHNMS | 326 | Q8TDX9 | |
| TGSMNVIHMLESFTF | 266 | O43781 | |
| ESTAFVQAMMEGSHT | 611 | Q92523 | |
| TGGMYESQQASVTMH | 101 | Q86V97 | |
| FNMSMSIKDRHESVG | 576 | Q15648 | |
| MMDNHSSATEFHLLG | 1 | Q8NGT5 | |
| MMFDGQSAVEVHSRT | 836 | Q16363 | |
| ELMRASASGHMSTAQ | 926 | Q8NET4 | |
| SASGHMSTAQTTAMV | 931 | Q8NET4 | |
| MAAARHSTLDFMLGA | 1 | P52788 | |
| NTSMDAGLSFIMANH | 196 | Q7Z4G4 | |
| VAHSTFSAMKANTMS | 241 | O00204 | |
| QEMFGSMFHAETLTA | 776 | Q7LBE3 | |
| EAGMETHIMTVFGHF | 661 | Q9UPU3 | |
| GHSSSAMLMLLSVVF | 1121 | Q9UPU3 | |
| TALSMVMHNYESSGI | 736 | Q9HCM1 | |
| VMSDGGFHEAQISNM | 61 | P52294 | |
| MSSLLDMGFSNAHIN | 96 | Q7Z6M4 | |
| SSHGNTMKQFMDIFS | 206 | Q86UY8 | |
| TSASVSTHMTAGAMA | 41 | Q9NYZ2 | |
| AAMNFQTMHNVTTET | 381 | Q9UNP4 | |
| DSTQVHMISAAMAGF | 116 | Q96CQ1 | |
| HMISAAMAGFTAITA | 121 | Q96CQ1 | |
| TNDGATILSMMDVDH | 71 | P48643 | |
| ITDSMVAAAMAHRGV | 226 | Q9BV20 | |
| SHMMDVQGSTQDSAI | 371 | P13667 | |
| HLSVMAAQSVYDTSM | 4616 | Q9P2P6 | |
| LSMGMSADFQHAVEV | 221 | O94903 | |
| HGDSTEFMGVNMDVI | 296 | Q9NPQ8 | |
| FNMFHMIAVGLSSSI | 966 | Q13591 | |
| MESAGIHETTYNSIM | 271 | P68032 | |
| NLMSTVHSDEAGMLS | 61 | Q9BWW9 | |
| STMSEGAQTMIEHNS | 341 | Q13188 | |
| EQQSDMVAMGTHANA | 181 | A0A0J9YY54 | |
| QLMMNGATSSFENGH | 561 | O15062 | |
| VADFGLITMTNTFHM | 1231 | Q96RL7 | |
| MAHFVQGTSRMIAAE | 1 | Q96KP6 | |
| SMAEVDAAMAARPHS | 71 | P22626 | |
| MLANLQATSEDMHGF | 966 | Q5TZJ5 | |
| QLTEHMTDMTFFSSV | 631 | Q0IIM8 | |
| FAHGGSLAAMMDETF | 156 | Q8N1Q8 | |
| FHERSSNMLSMENVG | 756 | Q6ZQQ2 | |
| HTDVSSFQTMDQMVS | 66 | P58340 | |
| ISHEVMSNMETFDVA | 281 | P56693 | |
| AHGMVAMVFKTLDDS | 696 | Q7Z5K2 | |
| MSVMDSHAVAQSVLT | 146 | Q92543 | |
| EFVMAAGTANTMHLL | 501 | Q8N392 | |
| EEMSNMFQSSGVQHH | 106 | Q9NQZ5 | |
| GSFGSRMTLVSNSHM | 26 | Q9ULL1 | |
| MHFSTVTRDMEAFTA | 1 | O43435 | |
| VIMHSNAIAAMTSSN | 726 | Q8NAP3 | |
| HMAAMSSAQIVSATA | 121 | P28347 | |
| ESAFSFSMLAAGVMH | 116 | O00744 | |
| FSMLAAGVMHAVATA | 121 | O00744 | |
| SSLSAVFEHFAMMQR | 296 | P04004 | |
| MLENFALMASLGHTS | 56 | Q68DY9 | |
| AHETTAELMNTAEMF | 506 | Q9NYU2 | |
| VHAELMGETMQSRFS | 196 | Q8IZJ6 | |
| FQMLSLEMSGSFHSS | 26 | Q0P140 | |
| YDANHGMLITGSSVM | 421 | B1ANS9 | |
| SIAFTSLDMFRSHMQ | 181 | Q5H9K5 | |
| SLDMFRSHMQGSEHQ | 186 | Q5H9K5 | |
| MSAAMAGLNTHTSAV | 256 | Q13887 |